Margaret O'Donnell, MD, on Novel Approaches to Treatment for Older AML Patients

James N. Kochenderfer, MD, on Preventing Progressive Malignancy After Stem Cell Transplant

James N. Kochenderfer, MD, of the National Cancer Institute, discusses a clinical trial of allogeneic T cells expressing an anti-CD19 chimeric antigen receptor, which caused remiss...

Leukemia

Lymphoma

Sagar Lonial, MD, and Alessandra Tedeschi, MD

Sagar Lonial, MD, and Alessandra Tedeschi, MD, on CLL/SLL: Results From the RESONATE-2 Trial

Sagar Lonial, MD, of the Emory University School of Medicine, and Alessandra Tedeschi, MD, of the Azienda Ospedaliera Niguarda Cà Granda, discuss this internationa...

Lymphoma

Stephen J. Schuster, MD

Stephen J. Schuster, MD, on CD19+ Lymphomas: Sustained Remissions in Relapsed or Refractory Disease

Stephen J. Schuster, MD, of the University of Pennsylvania, discusses the findings of a study of chimeric antigen receptor modified T cells directed against CD19 in patients with r...

Lymphoma

Ronald Go, MD

Ronald Go, MD, on Survival in NHL and Treatment Facility Volume

Ronald Go, MD, of the Mayo Clinic, discusses a study that used the National Cancer Data Base to determine the extent to which the number of non-Hodgkin lymphoma patients treated an...

Multiple Myeloma

David Henry, MD

David Henry, MD, on Multiple Myeloma: Expert Perspective

David Henry, MD, of Pennsylvania Hospital, discusses the exciting developments in multiple myeloma treatment, including the three new drugs approved for the disease in November 201...

Margaret O'Donnell, MD, on Novel Approaches to Treatment for Older AML Patients

Related Videos

James N. Kochenderfer, MD, on Preventing Progressive Malignancy After Stem Cell Transplant

Sagar Lonial, MD, and Alessandra Tedeschi, MD, on CLL/SLL: Results From the RESONATE-2 Trial

Stephen J. Schuster, MD, on CD19+ Lymphomas: Sustained Remissions in Relapsed or Refractory Disease

Ronald Go, MD, on Survival in NHL and Treatment Facility Volume

David Henry, MD, on Multiple Myeloma: Expert Perspective

Study Finds Patients With Bladder Cancer and Ureteric Obstruction May Safely Receive Chemotherapy

ORIENT-12 Study Addition of Sintilimab to Gemcitabine/Platinum in Advanced Squamous NSCLC

Addition of Neoadjuvant Chemotherapy to Surgery and Adjuvant S-1 in Locally Advanced Gastric Cancer

Study Explores Taste and Smell Dysfunction in Head and Neck Cancer Survivors

More Widespread Biomarker Testing for NSCLC in Oncology Practices and More Testing in Black Patients